Making Lung Cells from Pluripotent Stem Cells: Disease Modeling and Future Therapies

Human pluripotent stem cells (hPSCs) have the potential to provide inexhaustible sources of patient-specific cells, thus overcoming a major roadblock for many functional and pathological studies posed by the limited availability of patient-specific primary cells. Methods to differentiate hPSCs into specific cell types that exhibit functional characteristics of target adult cells hold great promise for patient-specific disease modeling, drug discovery and personalized medicine. In recent years, differentiation protocols for hPSC-derived airway epithelial cells have greatly improved the availability of cell models that enable studies of lung development and regeneration, as well as lung diseases, such as cystic fibrosis.

View this webinar presentation by Dr. Janet Rossant and Dr. Amy Wong (Hospital for Sick Children, Toronto), who discussed their research efforts to understand lung development and diseases using hPSC-derived lung epithelial cells in CF-patient specific models.

For speaker bios and additional educational resources, including Janet’s interview Q&A’s, please visit Pluripotent Learning Lounge.
Publish Date: August 12, 2016

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.